A Study to Assess ASP0598 Otic Solution Following Topical Application in the Ear in Subjects With Chronic Tympanic Membrane Perforation (CTMP)
Clinical trial NCT04305184 · TERMINATED
Trial details
- NCT number
- NCT04305184
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2023-01-24
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.